Agreement supports collaborative advancement of research in a range of therapeutic areas by researchers from across Harvard

Innovations in fluid injection, sequencing polynucleotides, isolation of white blood cells, DNA origami devices, film deposition, and more

Accelerator-supported research suggests engineered sacs called ARMMs may be uniquely suited to send therapeutics directly to affected areas of the body

Findings demonstrate that gut bacteria are potent catalysts of autoimmunity and pancreatic cell function; perturbations in microbiota can precipitate diabetes